Technology | Advanced Visualization | February 27, 2019

Philips Introduces IntelliSpace Portal 11 at ECR 2019

Latest release of Philips advanced visualization platform builds on intelligent clinical applications, hospital network connectivity and patient data security

Philips Introduces IntelliSpace Portal 11 at ECR 2019

February 27, 2019 — Philips announced the launch of IntelliSpace Portal 11, the latest release of the company’s comprehensive, advanced visualization and quantification software. Launching at the 2019 European Congress of Radiology (ECR), Feb. 27-March 3 in Vienna, Austria, the new version further extends the clinical innovation of the portal, with enhancements to improve workflow efficiencies, bridging secure data sharing between systems within the hospital network to address the security and privacy needs of customers globally.

Philips IntelliSpace Portal is an advanced visualization and analysis software solution designed to support diagnostic process, follow-up and communication across clinical domains and modalities, through a connected and secure workflow. The solution is a multimodality and multivendor comprehensive suite of advanced visualization solutions for radiology. It can scale to fit large scale enterprises, helping to maximize resources by leveraging analytical tools.

Philips IntelliSpace Portal 11 offers a seamless integrated portfolio of clinically rich applications for neurology, oncology and cardiology domains. The new version is focused on enhancing clinical workflow and automation via adaptive intelligence (aka artificial intelligence, or AI) functionalities, combining clinical data from multimodalities across the health continuum. The latest iteration also includes a new integrated Nuclear Medicine Viewer by Mirada Medical designed to support clinical challenges and productivity, with a dedicated optimized workflow for quantitative patient follow-up.

IntelliSpace Portal 11 introduces new zero-footprint viewer capabilities running directly through a web browser to provide anywhere access to advanced visualization data review during multi-disciplinary meetings inside or outside the hospital. Users can consult and share findings online with real-time peer to peer interaction. The viewer also offers scalability from a single department to an enterprise-wide solution. Philips noted that the zero-footprint viewer is not intended for diagnostic review.

Supporting patient data confidentiality, integrity and availability are part of the IntelliSpace Portal 11 security policy. The solution can be tailored to the customer environment, allowing flexible settings for patient and role-based access controls, designed to protect sensitive data from unauthorized access.

For more information: www.usa.philips.com/healthcare

Related Content

The key trends Clinicians reviewing a COVID-19 patient's lung CT that reveals the severity of COVID-caused pneumonia. The impact of COVID on radiology was a major, over arching trend at  the 2020 Radiological Society of North America (RSNA) meeting. Getty Imagesbserved at 2020 Radiological Society of North America (RSNA) meeting all focused around COVID-19 (SARS-CoV-2) and the impact it has had on radiology. #RSNA #RSNA20 #RSNA2020

Clinicians reviewing a COVID-19 patient's lung CT that reveals the severity of COVID-caused pneumonia. The impact of COVID on radiology was a major, over arching trend at  the 2020 Radiological Society of North America (RSNA) meeting. Getty Images

Feature | RSNA | January 20, 2021 | By Melinda Taschetta-Millane and Dave Fornell
Vendor neutral archives enable a single, central location to store large volumes of radiology data, but now need to be able to house data from dozens of other departments with a wide array of data formats. This article originally ran as an introduction to the Vendor Neutral Archives comparison chart.
Feature | Vendor Neutral Archive (VNA) | January 20, 2021 | By Dave Fornell
Most radiologists and clinicians are not trained as...
According to a new research report1 on the contrast media injectors published by MarketsandMarkets, the market was estimated to be $1.3 billion in 2020 and projected to reach $1.9 billion by 2025, at a compound annual growth rate (CAGR) of 7.4 percent over 2020-2025.

The ulrich CTmotion

Feature | Contrast Media Injectors | January 20, 2021 | By Melinda Taschetta-Millane
According to a new...
More complex, longer interventional procedures such as structural heart interventions or this revascularization of a coronary chronic total occlusion (CTO) at Henry Ford Hospital in Detroit, requires angiography imaging systems that have improved image detail and lower radiation dose. However, purchase of new systems was put on hold by many hospitals in 2020 due to the sudden drop in elective procedures and diversion of resources due to the COVID-19. Photo by Dave Fornell.

More complex, longer interventional procedures such as structural heart interventions or this revascularization of a coronary chronic total occlusion (CTO) at Henry Ford Hospital in Detroit, requires angiography imaging systems that have improved image detail and lower radiation dose. However, purchase of new systems was put on hold by many hospitals in 2020 due to the sudden drop in elective procedures and diversion of resources due to the COVID-19. Photo by Dave Fornell.

Feature | Angiography | January 19, 2021 | By Bhvita Jani
January 19, 2021 – With the postponement of non-essential elective surgeries and medical procedures in 2020 to conser
AI Metrics, LLC, a medical imaging startup focused on augmented intelligence to improve patient care, announced today that the U.S. Food and Drug Administration (FDA) has granted 510(k) clearance for the company’s flagship image analysis platform.
News | Artificial Intelligence | January 18, 2021
January 18, 2021 — AI Metrics, LLC, a medical imaging startup focused on augmented intelligence to improve patient ca
Use of telehealth jumped sharply during the first months of the coronavirus pandemic shutdown, with the approach being used more often for behavioral health services than for medical care, according to a new RAND Corporation study.

Getty Images

News | Teleradiology | January 13, 2021
January 13, 2021 — Use of telehealth jumped sha
This cutting-edge technology assists radiologists in the interpretation of screening mammograms and allows them to diagnose breast cancer earlier and more accurately
News | Mammography | January 12, 2021
January 12, 2021 — Therapixel announced that...
The U.S. Food and Drug Administration released the agency's first Artificial Intelligence/Machine Learning (AI/ML)-Based Software as a Medical Device (SaMD) Action Plan. This action plan describes a multi-pronged approach to advance the Agency's oversight of AI/ML-based medical software.
News | Artificial Intelligence | January 12, 2021
January 12, 2021 — The U.S.